Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1.

MLA

Rathore, Saima, et al. “Radiomic MRI Signature Reveals Three Distinct Subtypes of Glioblastoma with Different Clinical and Molecular Characteristics, Offering Prognostic Value beyond IDH1.” Scientific Reports, vol. 8, no. 1, Mar. 2018, p. 5087. EBSCOhost, https://doi.org/10.1038/s41598-018-22739-2.

APA

Rathore, S., Akbari, H., Rozycki, M., Abdullah, K. G., Nasrallah, M. P., Binder, Z. A., Davuluri, R. V., Lustig, R. A., Dahmane, N., Bilello, M., O’Rourke, D. M., & Davatzikos, C. (2018). Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1. Scientific Reports, 8(1), 5087. https://doi.org/10.1038/s41598-018-22739-2

Chicago

Rathore, Saima, Hamed Akbari, Martin Rozycki, Kalil G Abdullah, MacLean P Nasrallah, Zev A Binder, Ramana V Davuluri, et al. 2018. “Radiomic MRI Signature Reveals Three Distinct Subtypes of Glioblastoma with Different Clinical and Molecular Characteristics, Offering Prognostic Value beyond IDH1.” Scientific Reports 8 (1): 5087. doi:10.1038/s41598-018-22739-2.